Page last updated: 2024-11-04

sulfasalazine and Ovarian Neoplasms

sulfasalazine has been researched along with Ovarian Neoplasms in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research Excerpts

ExcerptRelevanceReference
"Ovarian cancer is characterized by high rates of metastasis and therapeutic resistance."1.39Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer. ( Singh, G; Verschoor, ML, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verschoor, ML1
Singh, G1

Other Studies

1 other study available for sulfasalazine and Ovarian Neoplasms

ArticleYear
Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.
    Molecular cancer, 2013, Nov-15, Volume: 12, Issue:1

    Topics: Amino Acid Transport System y+; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Drug Resi

2013